Breaking News Instant updates and real-time market news.

PACB

Pacific Biosciences

$9.05

0.18 (2.03%)

, ILMN

Illumina

$184.85

0.36 (0.20%)

17:13
10/10/16
10/10
17:13
10/10/16
17:13

Pacific Biosciences down 4.4%, QIAGEN down 1.8% after Illumina warning

PACB

Pacific Biosciences

$9.05

0.18 (2.03%)

ILMN

Illumina

$184.85

0.36 (0.20%)

QGEN

QIAGEN

$27.57

0.19 (0.69%)

A

Agilent

$47.69

0.31 (0.65%)

  • 10

    Oct

  • 01

    Nov

PACB Pacific Biosciences
$9.05

0.18 (2.03%)

04/22/16
CANT
04/22/16
NO CHANGE
CANT
Pacific Biosciences should be bought after strong Q1 results, says Cantor
Cantor recommends that investors buy the shares of Pacific Biosciences after the company reported stronger than expected Q1 results. The firm thinks that the company's increased guidance may be conservative, and it believes that the company could have at least 30 bookings in Q2. Cantor keeps an $18 price target and Buy rating on the shares.
04/18/16
PIPR
04/18/16
NO CHANGE
Target $11
PIPR
Neutral
Pacific Biosciences estimates lowered on Sequel checks at Piper Jaffray
Piper Jaffray analyst William Quirk lowered his Q1 estimates for Pacific Biosciences after his initial round of Sequel channel checks found six placements during the quarter compared to the 17 he modeled. Assuming Roche placed five systems, the Q1 total would come to 11, Quirk tells investors in a research note. The analyst keeps a Neutral rating on the shares with an $11 price target.
08/04/16
08/04/16
NO CHANGE

On The Fly: After Hours Movers
UP AFTER EARNINGS: Pacific Biosciences (PACB), up 17%... MasTec (MTZ), up 9.6%... Aratana Therapeutics (PETX), up 9.2%... Lion's Gate (LGF), up 6.4%... Priceline (PCLN), up 5.7%... Ubiquiti (UBNT), up 5.5%... MercadoLibre (MELI), up 4.1%... Organovo (ONVO), up 3.9%... Kraft Heinz (KHC), up 3.3%... EOG Resources (EOG), up 2.8%... Monster Beverage (MNST), up 1.2%... TASER (TASR), up 1.2%... Take-Two (TTWO), up 0.9%... Activision Blizzard (ATVI), up 1%... BioMarin (BMRN), up 0.4%. ALSO HIGHER: Egalet (EGLT), up 31.2% after the company announced that an FDA advisory committee recommended approval of its ARYMO ER drug... Rackspace (RAX), up 17.6% after the Wall Street Journal reported that the company was near a takeover deal with a private equity buyer... Osiris (OSIR), up 8.5% after it said that the manuscript from its prospective trial using Grafix was published. DOWN AFTER EARNINGS: Hortonworks (HDP), down 26.2%... PDL BioPharma (PDLI), down 17.5%... FireEye (FEYE), down 15.8%... Sierra Wireless (SWIR), down 15.6%... Aquinox (AQXP), down 14.7%... Zynga (ZNGA), down 9.4%... Universal Display (OLED), down 8.2%... Weight Watchers (WTW), down 7.6%... Zillow Group (Z, ZG), down 5.5%... Arista Networks (ANET), down 4.5%... Noodles & Company (NDLS), down 4.3%... Merrimack (MACK), down 1.7%... Bankrate (RATE), down 1.7%.
08/18/16
CANT
08/18/16
NO CHANGE
Target $165
CANT
Speculative Buy
Thermo Fisher unlikely to acquire Illumina, says Cantor
Cantor Fitzgerald analyst Bryan Brokmeier believes it is unlikely that Thermo Fisher (TMO) will attempt to acquire Illumina (ILMN). Even if Thermo were to attempt a deal, the merger would be unlikely to close, Brokmeier tells investors in an intraday research note. If Illumina is a willing seller, however, Roche (RHHBY) may reconsider a bid, the analyst contends. He recommends investors stay on the sidelines with respect to Illumina shares. Brokmeier has a Hold rating on the name with a $165 price target. The analyst continues to believe Roche is the most likely acquirer of Pacific Biosciences (PACB).
ILMN Illumina
$184.85

0.36 (0.20%)

08/22/16
KING
08/22/16
DOWNGRADE
KING
Neutral
Illumina downgraded to Neutral from Buy at CL King
CL King analyst David Westenberg downgraded Illumina to Neutral given the recent run-up in the shares and lack of near-term visible catalysts.
08/18/16
WELS
08/18/16
NO CHANGE
WELS
Wells Fargo says Thermo Fisher buying Illumina 'makes no sense'
Wells Fargo analyst Tim Evans believes speculation of Thermo Fisher (TMO) acquiring Illumina "makes no sense." The analyst estimates the deal would be about 14% dilutive to Thermo in year one and "would struggle to be neutral" to earnings by year three. Further, the deal would run into "significant regulatory hurdles" since that Illumina holds a near monopoly in high-throughput sequencing, Evans tell investors note. Shares of Illumina are off their highs but remain up 3% after StreetInsider stoked renewed takeout speculation by citing a source saying Thermo may bid $30B for the company.
09/12/16
SBSH
09/12/16
NO CHANGE
Target $190
SBSH
Buy
Illumina price target raised to $190 from $175 at Citi
Citi analyst Daniel Arias raised his price target for Illumina to $190 after traveling with the company's CFO Marc Stapley and investor relations head Rebecca Chambers. The analyst believes the business "can hold its own" in the second half of 2016 and that shares can move higher in 2017. He keeps a Buy rating on Illumina.
QGEN QIAGEN
$27.57

0.19 (0.69%)

11/12/15
STFL
11/12/15
INITIATION
STFL
Hold
QIAGEN initiated with a Hold at Stifel
05/25/16
PIPR
05/25/16
NO CHANGE
PIPR
Neutral
Piper says QIAGEN may need to change or pull GeneReader if Illumina wins suit
Piper Jaffray analyst William Quirk said patent infringement outcomes are hard to predict, but added that Illumina's (ILMN) win at the Patent Trial and Appeal Board increase its chances to prevail in its recently filed infringement lawsuit against Qiagen (QGEN) related to the GeneReader DNA sequencer. If Illumina does win, Qiagen will need to "drastically" alter the product and/or remove it from the market, said Quirk, who keeps a Neutral rating on Qiagen shares.
08/01/16
HSBC
08/01/16
UPGRADE
HSBC
Buy
QIAGEN upgraded to Buy from Hold at HSBC
HSBC analyst Keppeler upgraded QIAGEN to Buy and increased its price target to $27 from $20. The analyst is more constructive on improving trends in Academia/Pharma and expects topline growth to accelerate to 7% in 2017 from 1-4% in 2012-2015 from strong growth drivers that include QiaSymphony instrument and the NGS franchise.
11/12/15
11/12/15
INITIATION

On The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: Accuray (ARAY) initiated with a Sell at Citi... Becton Dickinson (BDX) initiated with a Neutral at Citi... Boston Scientific (BSX) initiated with a Buy at Citi... Bruker (BRKR) initiated with a Buy at Stifel... C.R. Bard (BCR) initiated with a Buy at Citi... Cepheid (CPHD) initiated with a Buy at Stifel... CorMedix (CRMD) initiated with a Buy at Rodman & Renshaw... CoreSite Realty (COR) initiated with a Buy at BB&T... Digital Realty (DLR) initiated with a Buy at BB&T... DuPont Fabros (DFT) initiated with a Hold at BB&T... Duke Realty (DRE) initiated with a Hold at BB&T... Edwards Lifesciences (EW) initiated with a Sell at Citi... Electronic Arts (EA) initiated with an Outperform at Oppenheimer... EyeGate (EYEG) initiated with a Buy at Maxim... Glu Mobile (GLUU) initiated with a Perform at Oppenheimer... Integra LifeSciences (IART) initiated with a Buy at Citi... Intuitive Surgical (ISRG) initiated with a Buy at Citi... Mast Therapeutics (MSTX) initiated with a Buy at Maxim... Medgenics (MDGN) initiated with a Buy at Needham... Novocure (NVCR) initiated with a Buy at Evercore ISI... Prologis (PLD) initiated with a Hold at BB&T... QIAGEN (QGEN) initiated with a Hold at Stifel... Rocket Fuel (FUEL) initiated with a Neutral at Boenning & Scattergood... STAG Industrial (STAG) initiated with an Underweight at BB&T... Stryker (SYK) initiated with a Sell at Citi... Tremor Video (TRMR) initiated with an Outperform at Boenning & Scattergood... VOXX (VOXX) initiated with an Outperform at Oppenheimer... Varian Medical (VAR) initiated with a Neutral at Citi... Yahoo (YHOO) initiated with an Outperform at Boenning & Scattergood... YuMe (YUME) initiated with a Neutral at Boenning & Scattergood... Zimmer Biomet (ZBH) initiated with a Sell at Citi.
A Agilent
$47.69

0.31 (0.65%)

05/23/16
JANY
05/23/16
NO CHANGE
JANY
Buy
Janney says Thermo Fisher not buying Agilent, but names some other targets
In a note to investors published Friday afternoon, Janney Capital analyst Paul Knight said he was surprised that Thermo Fisher (TMO) said at its analyst day that it intends to spend at least 70% of deployed capital, or $12B over four years, on M&A, noting he expected more buybacks. Knight said Agilent (A) is often mentioned as a Thermo target, but he does not see that deal happening given the antitrust hurdles. Knight said Thermo is likely to acquire in the biological production space, where there are limited candidates, and noted that Repligen (RGEN) "possesses a near monopoly" in Protein A ligands. There are also "easy adds" in biological reagents, Knight tells investors, noting that Bio-Techne (TECH) is one of the two leading reagent companies for research proteins and antibodies. The firm has a Buy rating on Thermo Fisher shares.
05/17/16
EVER
05/17/16
NO CHANGE
Target $48
EVER
Buy
Agilent price target raised to $48 on strong Q2 print at Evercore ISI
Evercore ISI analyst Ross Muken raised Agilent's price target to $48 from $43 citing the strong Q2 report driven by HSD core revenue growth, solid OMx exeuction, and impressive uptick free cash flow, and the guidance raise. Muken has increased confidence in execution and upside to his forecasts, and reiterates his Buy rating.
05/17/16
JANY
05/17/16
NO CHANGE
Target $52
JANY
Buy
Agilent current quarter guidance looks conservative, says Janney Capital
Janney Capital analyst Paul Knight said Agilent's results beat expectations on "every line" in the April quarter and he believes the company's guidance for the current quarter looks conservative. Knight, who expects tailwinds as academia improves and China gains visibility, raised his fair value estimate on Agilent shares to $52 from $45 and keeps a Buy rating on the name.
05/25/16
LEER
05/25/16
NO CHANGE
LEER
Outperform
Agilent analyst day reinforces margin expansion opportunity, says Leerink
Leerink analyst Dan Leonard said today's analyst day meeting held by Agilent reinforced his view that the company has more margin expansion opportunity that is "top-line independent" than its peers in the Life Science Tools space. The company's articulation of an opportunity to reduce its effective tax rate by 200bps over the next two years was an unexpected "nice surprise," added Leonard, who keeps an Outperform rating on the stock.

TODAY'S FREE FLY STORIES

BMRN

BioMarin

$82.45

0.24 (0.29%)

, ESALY

Eisai

$57.37

-0.545 (-0.94%)

04:55
12/06/16
12/06
04:55
12/06/16
04:55
Conference/Events
American Epilepsy Society to hold annual meeting »

70th Annual Meeting of…

BMRN

BioMarin

$82.45

0.24 (0.29%)

ESALY

Eisai

$57.37

-0.545 (-0.94%)

GWPH

GW Pharmaceuticals

$117.45

5.13 (4.57%)

IART

Integra LifeSciences

$76.78

1 (1.32%)

MDT

Medtronic

$71.67

-0.34 (-0.47%)

MNK

Mallinckrodt

$53.56

-0.05 (-0.09%)

NVTA

Invitae

$7.05

0.1 (1.44%)

SAGE

SAGE Therapeutics

$51.82

2.8 (5.71%)

WTKWY

Wolters Kluwer

$35.23

1.15 (3.37%)

ZGNX

Zogenix

$12.70

-0.35 (-2.68%)

ZYNE

Zynerba

$13.18

-0.46 (-3.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 07

    Dec

  • 12

    Dec

  • 14

    Dec

  • 28

    Jan

  • 27

    Apr

04:55
12/06/16
12/06
04:55
12/06/16
04:55
General news
Productivity and Costs Unit labor costs to be reported at 08:30 »

Productivity and Costs…

ADSK

Autodesk

$71.18

0.61 (0.86%)

04:55
12/06/16
12/06
04:55
12/06/16
04:55
Conference/Events
Autodesk to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 07

    Dec

  • 09

    Jan

GWB

Great Western

$40.42

0.99 (2.51%)

04:55
12/06/16
12/06
04:55
12/06/16
04:55
Conference/Events
Great Western management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 07

    Dec

ECL

Ecolab

$118.56

1.67 (1.43%)

04:55
12/06/16
12/06
04:55
12/06/16
04:55
Conference/Events
Ecolab management to meet with Jefferies »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 12

    Dec

CGNX

Cognex

$58.03

0.03 (0.05%)

04:55
12/06/16
12/06
04:55
12/06/16
04:55
Conference/Events
Cognex management to meet with Needham »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

SMCI

Super Micro Computer

$27.60

0.6 (2.22%)

04:55
12/06/16
12/06
04:55
12/06/16
04:55
Conference/Events
Super Micro Computer management to meet with Maxim »

Group dinner to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 08

    Feb

  • 09

    Feb

LLL

L-3 Communications

$158.46

1.23 (0.78%)

04:55
12/06/16
12/06
04:55
12/06/16
04:55
Conference/Events
L-3 Communications to host investor meeting with conference call hookup »

Investor meeting to be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 06

    Dec

CSV

Carriage Services

$27.79

0.29 (1.05%)

04:55
12/06/16
12/06
04:55
12/06/16
04:55
Conference/Events
Carriage Services management to meet with Barrington »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 07

    Dec

04:55
12/06/16
12/06
04:55
12/06/16
04:55
General news
Productivity and Costs Nonfarm productivity to be reported at 08:30 »

Productivity and Costs…

EKSO

Ekso Bionics

$4.67

0.4 (9.37%)

04:55
12/06/16
12/06
04:55
12/06/16
04:55
Conference/Events
Ekso Bionics to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

04:55
12/06/16
12/06
04:55
12/06/16
04:55
Conference/Events
American College of Neuropsychopharmacology to hold an annual meeting »

55th Annual Meeting of…

TWOU

2U

$32.15

0.99 (3.18%)

04:55
12/06/16
12/06
04:55
12/06/16
04:55
Conference/Events
2U management to meet with Needham »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 07

    Dec

04:55
12/06/16
12/06
04:55
12/06/16
04:55
General news
Factory Orders to be reported at 10:00 »

October Factory Orders…

RGLS

Regulus

$2.85

0.35 (14.00%)

04:55
12/06/16
12/06
04:55
12/06/16
04:55
Conference/Events
Regulus to host research and development day »

Research and Development…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 14

    Dec

AGO

Assured Guaranty

$36.95

0.4 (1.09%)

04:55
12/06/16
12/06
04:55
12/06/16
04:55
Conference/Events
Assured Guaranty management to meet with MKM Partners »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

CHEF

Chefs' Warehouse

$14.10

0.9 (6.82%)

, SFS

Smart & Final Stores

04:55
12/06/16
12/06
04:55
12/06/16
04:55
Conference/Events
Barclays to hold a conference »

2016 Eat, Sleep, Play:…

CHEF

Chefs' Warehouse

$14.10

0.9 (6.82%)

SFS

Smart & Final Stores

SAFM

Sanderson Farms

$85.90

3.94 (4.81%)

JACK

Jack in the Box

$108.24

1.09 (1.02%)

CAKE

Cheesecake Factory

$61.40

0.92 (1.52%)

KR

Kroger

$32.93

-0.37 (-1.11%)

YUM

Yum! Brands

$63.06

0.64 (1.03%)

SYY

Sysco

$53.48

-0.11 (-0.21%)

RLJ

RLJ Lodging Trust

$23.38

0.86 (3.82%)

RCL

Royal Caribbean

$81.05

1.49 (1.87%)

PENN

Penn National

$13.50

0.13 (0.97%)

MGM

MGM Resorts

$28.97

-0.04 (-0.14%)

MAR

Marriott

$81.00

1.8 (2.27%)

LVS

Las Vegas Sands

$61.12

0.13 (0.21%)

HT

Hersha Hospitality

$20.75

0.19 (0.92%)

EAT

Brinker

$53.43

0.15 (0.28%)

DPZ

Domino's Pizza

$166.29

-1.71 (-1.02%)

CMG

Chipotle

$396.27

-3.76 (-0.94%)

CHH

Choice Hotels

$52.75

0.85 (1.64%)

BOJA

Bojangles

$18.75

0.65 (3.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 06

    Dec

  • 07

    Dec

  • 13

    Dec

  • 15

    Dec

  • 09

    Jan

04:55
12/06/16
12/06
04:55
12/06/16
04:55
Conference/Events
KeyBanc to hold a conference »

Consumer Conference is…

ON

ON Semiconductor

$11.23

0.11 (0.99%)

04:55
12/06/16
12/06
04:55
12/06/16
04:55
Conference/Events
ON Semiconductor management to meet with B. Riley »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

ECOM

ChannelAdvisor

$14.30

0.25 (1.78%)

, BCOV

Brightcove

04:55
12/06/16
12/06
04:55
12/06/16
04:55
Conference/Events
Raymond James to hold a conference »

Technology Investors…

ECOM

ChannelAdvisor

$14.30

0.25 (1.78%)

BCOV

Brightcove

EXTR

Extreme Networks

$4.43

0.15 (3.50%)

CTRL

Control4

$11.19

0.07 (0.63%)

JNPR

Juniper

$26.93

0.1 (0.37%)

SNX

SYNNEX

$121.70

2.97 (2.50%)

GIG

GigPeak

$2.62

0.15 (6.07%)

QRVO

Qorvo

$52.48

1.94 (3.84%)

FLEX

Flex

$14.55

0.17 (1.18%)

WK

Workiva

BNFT

Benefitfocus

$28.20

1.1 (4.06%)

HAR

Harman

$109.66

0.19 (0.17%)

FIT

Fitbit

$8.03

-0.11 (-1.35%)

ULTI

Ultimate Software

$192.96

1.56 (0.82%)

CRTO

Criteo

$39.33

0.65 (1.68%)

MSCC

Microsemi

$53.40

0.45 (0.85%)

VC

Visteon

$79.86

0.05 (0.06%)

ADI

Analog Devices

$70.60

0.49 (0.70%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 06

    Dec

  • 07

    Dec

  • 07

    Dec

  • 08

    Dec

  • 13

    Dec

  • 14

    Dec

  • 05

    Jan

  • 10

    Jan

  • 14

    Feb

APTS

Preferred Apartment

$13.48

0.07 (0.52%)

04:55
12/06/16
12/06
04:55
12/06/16
04:55
Conference/Events
Preferred Apartment management to meet with JMP Securities »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

PLNT

Planet Fitness

$20.17

0.15 (0.75%)

04:55
12/06/16
12/06
04:55
12/06/16
04:55
Conference/Events
Planet Fitness management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 09

    Jan

SUM

Summit Materials

$23.53

0.27 (1.16%)

04:55
12/06/16
12/06
04:55
12/06/16
04:55
Conference/Events
Summit Materials management to meet with Stephens »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 19

    Dec

CSIQ

Canadian Solar

$11.79

0.72 (6.50%)

04:55
12/06/16
12/06
04:55
12/06/16
04:55
Conference/Events
Canadian Solar management to meet with Roth Capital »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 09

    Dec

CEVA

CEVA

$30.75

0.9 (3.02%)

04:55
12/06/16
12/06
04:55
12/06/16
04:55
Conference/Events
CEVA management to meet with Roth Capital »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

  • 07

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.